Codexis, Inc. (CDXS) CEO John Nicols on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
Codexis, Inc. (CDXS) CEO John Nicols on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Codexis and Molecular Assemblies Partner to Transform the Field of DNA SynthesisGlobeNewsWire • 06/23/20
Codexis Announces the Election of New Directors at its Annual Meeting of StockholdersGlobeNewsWire • 06/16/20
Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic MarketsGlobeNewsWire • 06/01/20
Codexis, Inc. (CDXS) CEO John Nicols on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/10/20
Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic DisordersGlobeNewsWire • 03/23/20
Codexis, Inc. (CDXS) CEO John Nicols on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/28/20
Codexis Is Chasing a Blockbuster Opportunity. Can It Compete With Gene Therapies?The Motley Fool • 01/28/20